ZIOP vs. ETF Alternatives
ZIOPHARM Oncology Inc is a biopharmaceutical company. The Company is engaged in the acquiring, developing and commercializing portfolio of cancer therapies that can address unmet medical needs through synthetic biology.
The Zacks Analyst Blog Highlights: Amazon.com, LendingTree, Dycom Industries, Exelixis and ZIOPHARM Oncologyat Zacks.com (Nov 5, 2015)
at Zacks.com (Sep 16, 2015)
ZIOPHARM ONCOLOGY : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)at 4-traders.com (Aug 21, 2015)
at Nasdaq.com (Aug 14, 2015)
ZIOPHARM ONCOLOGY : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)at 4-traders.com (May 15, 2015)
Other News & PR